Changes in Cancer Stem Cell Signalling Pathways With Plant Metabolites to Discover Chemotherapy.

Area of Science:

• Oncology
• Metabolomics
• Pharmacology

Background:

• Cancer stem cells (CSCs) exhibit distinct metabolic profiles compared to bulk tumor cells.
• Understanding these metabolic differences is crucial for developing targeted cancer therapies.

Purpose of the Study:

• To explore the metabolic and biological disparities between CSCs and bulk tumor cells.
• To investigate the potential of plant metabolites in modulating CSC signaling pathways.
• To discuss the chemotherapeutic and chemopreventive applications of plant metabolites in cancer drug discovery.

Main Methods:

• Comparative analysis of metabolic and biological characteristics of CSCs and bulk tumor cells.
• Review of existing literature on plant metabolites and their effects on CSC signaling.
• Discussion of specific plant metabolites: curcumin, resveratrol, epigallocatechin gallate (EGCG), and genistein.

Main Results:

• Plant metabolites can re-orchestrate CSC signaling pathways, inducing differentiation or cell death.
• Curcumin, resveratrol, EGCG, and genistein demonstrate the ability to alter CSC signaling.
• These compounds show promise for both chemotherapeutic and chemopreventive strategies.

Conclusions:

• Plant metabolites offer a promising avenue for targeting CSCs due to their unique metabolic vulnerabilities.
• Further research into plant metabolites could lead to novel cancer drug discovery and development.
• The chemopreventive potential of these compounds warrants significant investigation.